Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Champions Oncology Reports Revenue of $16.6 Million
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
Dow Settles Lower But Records Weekly Gain: Investor Sentiment Declines, Greed Index Moves To 'Fear' Zone
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
Champions Oncology Reports Record Annual Revenue of $57 Million
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025
Champions Oncology Announces Appointment of New CEO
Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models
Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025
Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting